Data as of 11:39am ET
| +0.19 / +0.91%|
The 3 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 24.00. The median estimate represents a +42.18% increase from the last price of 21.10.
The current consensus among 4 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.